XML 88 R63.htm IDEA: XBRL DOCUMENT v3.20.4
Employee Benefit Plans (Narrative) (Details) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
May 20, 2020
Jan. 01, 2021
Jan. 03, 2020
Dec. 28, 2018
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Number of shares available for grant   17,100,727    
Reduction in share reserve after stock option or stock appreciation award (in shares)   1    
Reduction in share reserve after all other awards (in shares)   1.5    
Increase in share reserve under 2017 plan (in shares) 21,000,000      
Total stock-based compensation expense   $ 105,070 $ 56,602 $ 40,626
Stock options granted (in shares)   1,637,000    
Expenses relating to stock match   $ 6,700 4,600 3,600
Stock options        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Expiration period   7 years    
Total stock-based compensation expense   $ 19,863 23,422 18,896
Total unrecognized compensation expense   $ 27,100    
Unrecognized compensation expense weighted-average period for recognition   2 years 3 months 18 days    
Intrinsic value of options exercised   $ 106,500 54,100 39,100
Cash received from option exercises and purchases under the ESPP   $ 26,900 16,400 12,100
Stock options | Share-based Payment Arrangement, Employee        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Award vesting period   4 years    
Stock options | Share-based Payment Arrangement, Nonemployee        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Award vesting period   1 year    
Restricted stock units        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Total stock-based compensation expense   $ 35,675 $ 26,056 19,569
Total unrecognized compensation expense   $ 103,600    
Unrecognized compensation expense weighted-average period for recognition   3 years    
Instruments awarded (in shares)   3,053,000    
Number of awards (in shares)   5,378,000 4,422,000  
Restricted stock units | Share-based Payment Arrangement, Employee        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Award vesting period   4 years    
Restricted stock units | Share-based Payment Arrangement, Nonemployee        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Award vesting period   1 year    
ESPP        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Number of shares available for grant   3,704,580    
Discount rate from market value on purchase date (as a percent)   85.00%    
Discount rate from market value on offering date (as a percent)   85.00%    
Purchase period   6 months    
Total stock-based compensation expense   $ 2,426 $ 2,246 $ 2,161
Common stock issued (in shares)   534,419 483,009 330,492
Average price per share (in dollars per share)   $ 14.55 $ 12.60 $ 15.74
Proceeds from employee stock purchase plan   $ 7,800 $ 6,100 $ 5,200
Performance Share Options (PSO)        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Stock options granted (in shares)       308,365
Exercise threshold, percentage of per share exercise price of the PSO       125.00%
Performance stock units        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Total stock-based compensation expense   $ 47,106 $ 4,878 $ 0
Unrecognized compensation expense weighted-average period for recognition   3 years 6 months    
Instruments awarded (in shares)   4,656,000 1,926,605 693,131
Employees percentage   200.00% 200.00%  
Additional shares to be earned (in shares)   4,655,680 1,926,605  
Number of awards (in shares)   7,378,000 4,379,000  
Performance stock units | Achieved        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Number of awards (in shares)   3,206,897    
Performance stock units | Probable        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Total unrecognized compensation expense   $ 11,800    
Performance stock units | Not Probable        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Total unrecognized compensation expense   $ 128,500    
Performance Shares, Clinical Trial Results        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Instruments awarded (in shares)   2,327,840    
Performance Shares, Achieved Before December 31, 2020        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Employees percentage     150.00%  
Performance Shares, Achieved Before December 31, 2021        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Employees percentage     50.00%